Seminars

The UAB Comprehensive Cancer Center hosts a monthly seminar series that is open to all faculty and staff. For more information, contact Susan Ruppert at 975-0359 or sruppert@uab.edu.

2015 Seminars:
Unless noted, all seminars will be held in the Wallace Tumor Institute Conference Room 101.

January 13, 2015
Ted Kaptchuk, Professor of Medicine, Harvard Medical School; Director, Program of Placebo Studies &Therapeutic Encounter, Beth Israel Deaconess Medical Center
Placebo Effects: How is Medicine More Than Drugs and Surgery?
12:00 – 1:00 p.m.

January 23, 2015
Ritu Aneja, Ph.D., Professor, Department of Biology; Director of Graduate Studies in Biology; Georgia State University, Atlanta
How to be Good at Being Bad: Centrosome Amplification, Clustering, and Mitotic Propensity are the Dark Art Weaponry of Cancer Cells
12:00 – 1:00 p.m.

February 4, 2015
Kasturi Mitra, Ph.D., Assistant Professor, Department of Genetics, Division of Research; Associate Scientist, UAB Comprehensive Cancer Center, Cancer Cell Biology Program
Mitochondrial Fission Protein DRP1 as an Emerging Tumor Suppressor
12:00 – 1:00 p.m.

February 9, 2015
Go van Dam, M.D., Ph.D., Principal Investigator at Optical Imaging Research Group Groningen (OIRGG); Professor Surgical Oncology, University Medical Center Groningen; Groningen, The Netherlands
2:00 – 3:00 p.m.

March 30, 2015
Jeffrey H. Silber, M.D., Ph.D., Director, Center for Outcomes Research; The Nancy Abramson Wolfson Endowed Chair in Health Services Research, Children’s Hospital of Philadelphia; Professor of Pediatrics, Anesthesiology and Critical Care, Perelman School of Medicine; Professor of Health Care Management, The Wharton School, University of Pennsylvania
Using multivariate matching to examine racial disparities in cancer outcomes
12:00 – 1:00 p.m.

April 8, 2015
James Rocco, M.D., Ph.D., Professor and John and Mary Alford Chair of Head and Neck Surgery, The Ohio State University Wexner Medical Center; Director, Division of Head and Neck Oncologic Surgery; Medical Director, Head and Neck Service Line; James Cancer Hospital/Solove Research Institute; Co-Director, Head and Neck Disease Specific Research Group OSU-CCC
Using next generation sequencing to predict outcome in head and neck squamous cell carcinoma
12:00 – 1:00 p.m.

May 15, 2015
Ichiro Nakano, M.D., Ph.D., Associate Professor, Director, Neural Cancer Stem Cell Program, Department of Neurological Surgery, James Comprehensive Cancer Center, Columbus, OH
Brain Cancer Stem Cell-Directed Therapeutic Development
12:00 – 1:00 p.m.

August 5, 2015
Shi-Yong Sun, Ph.D., Professor and Halpern Research Scholar, GRA Distinguished Cancer Scientist, Department of Hematology and Medical Oncology, Emory Winship Cancer Institute, Emory University School of Medicine
Understanding and Targeting Death Receptor 5 in Cancer Therapy
12:00 – 1:00 p.m.

September 2, 2015
Richard Lanman, M.D., Chief Medical Officer, Guardant Health
12:00 – 1:00 p.m.

September 23, 2015
Michael Nickerson, Ph.D., Staff Scientist, Center for Cancer Research, National Cancer Institute, Frederick, Maryland (Guest of Sunil Sudarshan, M.D.)
A Nexus of Interacting Urologic Cancer Proteins Enriched in Epigenetic Functions
12:00 – 1:00 p.m.
North Pavilion Board Room 2532

December 2, 2015
Shih-Hsin “Eddy” Yang, M.D., Ph.D., Associate Professor, UAB Department of Radiation Oncology; ROAR Southeast Cancer Foundation Endowed Chair; Scientist, UAB Comprehensive Cancer Center

 

Previous Seminars

Leave a Reply